254 related articles for article (PubMed ID: 15027769)
1. Prevalence of hepatitis B and C viruses in pre-dialysis patients with chronic renal failure.
Salako BL; Ayodele OE; Kadiri S; Arije A
Afr J Med Med Sci; 2002 Dec; 31(4):311-4. PubMed ID: 15027769
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H
Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434
[TBL] [Abstract][Full Text] [Related]
3. HBV-DNA in hemodialysis patients infected by HCV.
Arababadi MK; Hassanshahi G; Yousefi H
Saudi J Kidney Dis Transpl; 2009 May; 20(3):398-401. PubMed ID: 19414941
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of hepatitis C and B infection and HC V genotypes among hemodialysis patients in Khuzestan province, southwest Iran.
Assarehzadegan MA; Shakerinejad G; Noroozkohnejad R; Amini A; Rahim Rezaee SA
Saudi J Kidney Dis Transpl; 2009 Jul; 20(4):681-4. PubMed ID: 19587521
[TBL] [Abstract][Full Text] [Related]
5. Decreased serum aminotransferase activity in patients with chronic renal failure: impact on the detection of viral hepatitis.
Fabrizi F; Lunghi G; Finazzi S; Colucci P; Pagano A; Ponticelli C; Locatelli F
Am J Kidney Dis; 2001 Nov; 38(5):1009-15. PubMed ID: 11684554
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of hepatitis B and C viruses in patients with chronic kidney disease in the predialysis stage at a university hospital in Turkey.
Sit D; Kadiroglu AK; Kayabasi H; Yilmaz ME; Goral V
Intervirology; 2007; 50(2):133-7. PubMed ID: 17191015
[TBL] [Abstract][Full Text] [Related]
7. Different kinetics of HBV and HCV during haemodialysis and absence of seronegative viral hepatitis in patients with end-stage renal disease.
Mederacke I; Meier M; Lüth JB; Schmidt-Gürtler H; Raupach R; Horn-Wichmann R; Wursthorn K; Potthoff A; Colucci G; Manns MP; Wedemeyer H; Tillmann HL
Nephrol Dial Transplant; 2011 Aug; 26(8):2648-56. PubMed ID: 21273235
[TBL] [Abstract][Full Text] [Related]
8. [Investigation of hemodialysis patients in terms of the presence of occult hepatitis B].
Altindiş M; Uslan I; Cetinkaya Z; Yüksel S; Ciftçi IH; Demirtürk N; Ozdemir M; Arslan F; Aktepe OC
Mikrobiyol Bul; 2007 Apr; 41(2):227-33. PubMed ID: 17682709
[TBL] [Abstract][Full Text] [Related]
9. Changing epidemiology of HCV and HBV infections in Northern Italy: a survey in the general population.
Fabris P; Baldo V; Baldovin T; Bellotto E; Rassu M; Trivello R; Tramarin A; Tositti G; Floreani A
J Clin Gastroenterol; 2008; 42(5):527-32. PubMed ID: 18277889
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of hepatitis B and C markers in glomerular diseases.
Enríquez R; Rodríguez JC; Sirvent AE; Amorós F; Ardoy F; Alvarez M; Royo G
Scand J Urol Nephrol; 2007; 41(6):535-8. PubMed ID: 17853005
[TBL] [Abstract][Full Text] [Related]
11. Antibodies to hepatitis C virus (HCV) in chronic renal failure (CRF) patients on conservative therapy: prevalence, risk factors and relationship to liver disease.
Fabrizi F; Marcelli D; Bacchini G; Guarnori I; Erba G; Locatelli F
Nephrol Dial Transplant; 1994; 9(7):780-4. PubMed ID: 7526275
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of hepatitis C virus and hepatitis B virus among dialysis patients in Bahrain and Saudi Arabia.
Almawi WY; Qadi AA; Tamim H; Ameen G; Bu-Ali A; Arrayid S; Abou Jaoude MM
Transplant Proc; 2004; 36(6):1824-6. PubMed ID: 15350487
[TBL] [Abstract][Full Text] [Related]
13. Occult hepatitis B in renal transplant patients.
Peres AA; Dias EA; Chesky M; Alvares-da-Silva MR; Jobim LF; Gonçalves LF; Manfro RC
Transpl Infect Dis; 2005 Jun; 7(2):51-6. PubMed ID: 16150090
[TBL] [Abstract][Full Text] [Related]
14. Outcome of hepatitis B and C virus infection on graft function after renal transplantation.
Behzad-Behbahani A; Mojiri A; Tabei SZ; Farhadi-Andarabi A; Pouransari R; Yaghobi R; Rahsaz M; Banihashemi M; Malek-Hosseini SA; Javid A; Bahador A; Reisjalali A; Behzadi S; Salehipour M; Salahl A; Davari R; Janghorban P; Torb A; Salah AR
Transplant Proc; 2005 Sep; 37(7):3045-7. PubMed ID: 16213299
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C infection in a pediatric dialysis population.
Jonas MM; Zilleruelo GE; LaRue SI; Abitbol C; Strauss J; Lu Y
Pediatrics; 1992 Apr; 89(4 Pt 2):707-9. PubMed ID: 1313556
[TBL] [Abstract][Full Text] [Related]
17. [Prevalance of antibodies against hepatitis C and B viruses in patients with systemic lupus erythematosus].
Mercado U; Avendaño-Reyes M; Araiza-Casillas R; Díaz-Molina R
Rev Gastroenterol Mex; 2005; 70(4):399-401. PubMed ID: 17058978
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus and hepatitis C virus seroprevalence in rural areas of the southwestern region of Turkey.
Akcam FZ; Uskun E; Avsar K; Songur Y
Int J Infect Dis; 2009 Mar; 13(2):274-84. PubMed ID: 18945630
[TBL] [Abstract][Full Text] [Related]
19. Viral hepatitis infections in southern Taiwan: a multicenter community-based study.
Yang JF; Lin CI; Huang JF; Dai CY; Lin WY; Ho CK; Hsieh MY; Lee LP; Ho NJ; Lin ZY; Chen SC; Hsieh MY; Wang LY; Yu ML; Chuang WL; Chang WY
Kaohsiung J Med Sci; 2010 Sep; 26(9):461-9. PubMed ID: 20837342
[TBL] [Abstract][Full Text] [Related]
20. [Hepatitis B virus markers and anti-HCV antibodies in hemodialyzed patients].
Illés M; Szontágh L; Gál G
Orv Hetil; 1992 Jul; 133 Suppl 1():27-30. PubMed ID: 1630802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]